ObjectiveTo develop and validate machine learning (ML) models for objective and comprehensive quantification of sagittal craniosynostosis (SCS) severity, enhancing clinical assessment, management, and research.DesignA cross-sectional study that combined the analysis of computed tomography (CT) scans and expert ratings.SettingThe study was conducted at a children's hospital and a major computer imaging institution. Our survey collected expert ratings from participating surgeons.ParticipantsThe study included 195 patients with nonsyndromic SCS, 221 patients with nonsyndromic metopic craniosynostosis (CS), and 178 age-matched controls. Fifty-four craniofacial surgeons participated in rating 20 patients head CT scans.InterventionsComputed tomography scans for cranial morphology assessment and a radiographic diagnosis of nonsyndromic SCS.Main OutcomesAccuracy of the proposed Sagittal Severity Score (SSS) in predicting expert ratings compared to cephalic index (CI). Secondary outcomes compared Likert ratings with SCS status, the predictive power of skull-based versus skin-based landmarks, and assessments of an unsupervised ML model, the Cranial Morphology Deviation (CMD), as an alternative without ratings.ResultsThe SSS achieved significantly higher accuracy in predicting expert responses than CI (<i>P</i> < .05). Likert ratings outperformed SCS status in supervising ML models to quantify within-group variations. Skin-based landmarks demonstrated equivalent predictive power as skull landmarks (<i>P</i> < .05, threshold 0.02). The CMD demonstrated a strong correlation with the SSS (Pearson coefficient: 0.92, Spearman coefficient: 0.90, <i>P</i> < .01).ConclusionsThe SSS and CMD can provide accurate, consistent, and comprehensive quantification of SCS severity. Implementing these data-driven ML models can significantly advance CS care through standardized assessments, enhanced precision, and informed surgical planning.

For magnetic resonance imaging (MRI), a short acquisition time and good image quality are incompatible. Thus, reconstructing time-resolved volumetric MRI (4D-MRI) to delineate and monitor thoracic and upper abdominal tumor movements is a challenge. Existing MRI sequences have limited applicability to 4D-MRI. A method is proposed for reconstructing high-quality personalized enhanced 4D-MR images. Low-quality 4D-MR images are scanned followed by deep learning-based personalization to generate high-quality 4D-MR images. High-speed multiphase 3D fast spoiled gradient recalled echo (FSPGR) sequences were utilized to generate low-quality enhanced free-breathing 4D-MR images and paired low-/high-quality breath-holding 4D-MR images for 58 liver cancer patients. Then, a personalized model guided by the paired breath-holding 4D-MR images was developed for each patient to cope with patient heterogeneity. The 4D-MR images generated by the personalized model were of much higher quality compared with the low-quality 4D-MRI images obtained by conventional scanning as demonstrated by significant improvements in the peak signal-to-noise ratio, structural similarity, normalized root mean square error, and cumulative probability of blur detection. The introduction of individualized information helped the personalized model demonstrate a statistically significant improvement compared to the general model (p < 0.001). The proposed method can be used to quickly reconstruct high-quality 4D-MR images and is potentially applicable to radiotherapy for liver cancer.

The accurate segmentation of myocardial scars from cardiac MRI is essential for clinical assessment and treatment planning. In this study, we propose a robust deep-learning pipeline for fully automated myocardial scar detection and segmentation by fine-tuning state-of-the-art models. The method explicitly addresses challenges of label noise from semi-automatic annotations, data heterogeneity, and class imbalance through the use of Kullback-Leibler loss and extensive data augmentation. We evaluate the model's performance on both acute and chronic cases and demonstrate its ability to produce accurate and smooth segmentations despite noisy labels. In particular, our approach outperforms state-of-the-art models like nnU-Net and shows strong generalizability in an out-of-distribution test set, highlighting its robustness across various imaging conditions and clinical tasks. These results establish a reliable foundation for automated myocardial scar quantification and support the broader clinical adoption of deep learning in cardiac imaging.

Multimodal Large Language Models (MLLMs) have emerged as a promising way to automate Radiology Report Generation (RRG). In this work, we systematically investigate the design space of 3D MLLMs, including visual input representation, projectors, Large Language Models (LLMs), and fine-tuning techniques for 3D CT report generation. We also introduce two knowledge-based report augmentation methods that improve performance on the GREEN score by up to 10\%, achieving the 2nd place on the MICCAI 2024 AMOS-MM challenge. Our results on the 1,687 cases from the AMOS-MM dataset show that RRG is largely independent of the size of LLM under the same training protocol. We also show that larger volume size does not always improve performance if the original ViT was pre-trained on a smaller volume size. Lastly, we show that using a segmentation mask along with the CT volume improves performance. The code is publicly available at https://github.com/bowang-lab/AMOS-MM-Solution

Deep learning-based semantic segmentation approaches provide an efficient and automated means for cancer diagnosis and monitoring, which is important in clinical applications. However, implementing these approaches outside the experimental environment and using them in real-world applications requires powerful and adequate hardware resources, which are not available in most hospitals, especially in low- and middle-income countries. Consequently, clinical settings will never use most of these algorithms, or at best, their adoption will be relatively limited. To address these issues, some approaches that reduce computational costs were proposed, but they performed poorly and failed to produce satisfactory results. Therefore, finding a method that overcomes these limitations without losing performance is highly challenging. To face this challenge, our study proposes a novel, optimal convolutional neural network-based approach for medical image segmentation that consists of multiple synthesis and analysis paths connected through a series of long skip connections. The design leverages multi-scale convolution, multi-scale feature extraction, downsampling strategies, and feature map fusion methods, all of which have proven effective in enhancing performance. This framework was extensively evaluated against current state-of-the-art architectures on various medical image segmentation tasks, including lung tumors, spleen, and pancreatic tumors. The results of these experiments conclusively demonstrate the efficacy of the proposed approach in outperforming existing state-of-the-art methods across multiple evaluation metrics. This superiority is further enhanced by the framework's ability to minimize the computational complexity and decrease the number of parameters required, resulting in greater segmentation accuracy, faster processing, and better implementation efficiency.

To evaluate the depiction capability of fine lung nodules and airways using high-resolution settings on ultra-high-resolution energy-integrating detector CT (UHR-CT), incorporating large matrix sizes, thin-slice thickness, and iterative reconstruction (IR)/deep-learning reconstruction (DLR), using cadaveric human lungs and corresponding histological images. Images of 20 lungs were acquired using conventional CT (CCT), UHR-CT, and photon-counting detector CT (PCD-CT). CCT images were reconstructed with a 512 matrix and IR (CCT-512-IR). UHR-CT images were reconstructed with four settings by varying the matrix size and the reconstruction method: UHR-512-IR, UHR-1024-IR, UHR-2048-IR, and UHR-1024-DLR. Two imaging settings of PCD-CT were used: PCD-512-IR and PCD-1024-IR. CT images were visually evaluated and compared with histology. Overall, 6769 nodules (median: 1321 µm) and 92 airways (median: 851 µm) were evaluated. For nodules, UHR-2048-IR outperformed CCT-512-IR, UHR-512-IR, and UHR-1024-IR (p < 0.001). UHR-1024-DLR showed no significant difference from UHR-2048-IR in the overall nodule score after Bonferroni correction (uncorrected p = 0.043); however, for nodules > 1000 μm, UHR-2048-IR demonstrated significantly better scores than UHR-1024-DLR (p = 0.003). For airways, UHR-1024-IR and UHR-512-IR showed significant differences (p < 0.001), with no notable differences among UHR-1024-IR, UHR-2048-IR, and UHR-1024-DLR. UHR-2048-IR detected nodules and airways with median diameters of 604 µm and 699 µm, respectively. No significant difference was observed between UHR-512-IR and PCD-512-IR (p > 0.1). PCD-1024-IR outperformed UHR-CTs for nodules > 1000 μm (p ≤ 0.001), while UHR-1024-DLR outperformed PCD-1024-IR for airways > 1000 μm (p = 0.005). UHR-2048-IR demonstrated the highest scores among the evaluated EID-CT images. UHR-CT showed potential for detecting submillimeter nodules and airways. With the 512 matrix, UHR-CT demonstrated performance comparable to PCD-CT. Question There are scarce data evaluating the depiction capabilities of ultra-high-resolution energy-integrating detector CT (UHR-CT) for fine structures, nor any comparisons with photon-counting detector CT (PCD-CT). Findings UHR-CT depicted nodules and airways with median diameters of 604 µm and 699 µm, showing no significant difference from PCD-CT with the 512 matrix. Clinical relevance High-resolution imaging is crucial for lung diagnosis. UHR-CT has the potential to contribute to pulmonary nodule diagnosis and airway disease evaluation by detecting fine opacities and airways.

This study introduces a novel evaluation framework, GPTRadScore, to systematically assess the performance of multimodal large language models (MLLMs) in generating clinically accurate findings from CT imaging. Specifically, GPTRadScore leverages LLMs as an evaluation metric, aiming to provide a more accurate and clinically informed assessment than traditional language-specific methods. Using this framework, we evaluate the capability of several MLLMs, including GPT-4 with Vision (GPT-4V), Gemini Pro Vision, LLaVA-Med, and RadFM, to interpret findings in CT scans. This retrospective study leverages a subset of the public DeepLesion dataset to evaluate the performance of several multimodal LLMs in describing findings in CT slices. GPTRadScore was developed to assess the generated descriptions (location, body part, and type) using GPT-4, alongside traditional metrics. RadFM was fine-tuned using a subset of the DeepLesion dataset with additional labeled examples targeting complex findings. Post fine-tuning, performance was reassessed using GPTRadScore to measure accuracy improvements. Evaluations demonstrated a high correlation of GPTRadScore with clinician assessments, with Pearson's correlation coefficients of 0.87, 0.91, 0.75, 0.90, and 0.89. These results highlight its superiority over traditional metrics, such as BLEU, METEOR, and ROUGE, and indicate that GPTRadScore can serve as a reliable evaluation metric. Using GPTRadScore, it was observed that while GPT-4V and Gemini Pro Vision outperformed other models, significant areas for improvement remain, primarily due to limitations in the datasets used for training. Fine-tuning RadFM resulted in substantial accuracy gains: location accuracy increased from 3.41% to 12.8%, body part accuracy improved from 29.12% to 53%, and type accuracy rose from 9.24% to 30%. These findings reinforce the hypothesis that fine-tuning RadFM can significantly enhance its performance. GPT-4 effectively correlates with expert assessments, validating its use as a reliable metric for evaluating multimodal LLMs in radiological diagnostics. Additionally, the results underscore the efficacy of fine-tuning approaches in improving the descriptive accuracy of LLM-generated medical imaging findings.

Differentiating intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) is essential for selecting the most effective treatment strategies. However, traditional imaging modalities and serum biomarkers often lack sufficient specificity. Radiomics, a sophisticated image analysis approach that derives quantitative data from medical imaging, has emerged as a promising non-invasive tool. To systematically review and meta-analyze the radiomics diagnostic accuracy in differentiating ICC from HCC. PubMed, EMBASE, and Web of Science databases were systematically searched through January 24, 2025. Studies evaluating radiomics models for distinguishing ICC from HCC were included. Assessing the quality of included studies was done by using Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) and METhodological RadiomICs Score tools. Pooled sensitivity, specificity, and area under the curve (AUC) were calculated using a bivariate random-effects model. Subgroup and publication bias analyses were also performed. 12 studies with 2541 patients were included, with 14 validation cohorts entered into meta-analysis. The pooled sensitivity and specificity of radiomics models were 0.82 (95% CI: 0.76-0.86) and 0.90 (95% CI: 0.85-0.93), respectively, with an AUC of 0.88 (95% CI: 0.85-0.91). Subgroup analyses revealed variations based on segmentation method, software used, and sample size, though not all differences were statistically significant. Publication bias was not detected. Radiomics demonstrates high diagnostic accuracy in distinguishing ICC from HCC and offers a non-invasive adjunct to conventional diagnostics. Further prospective, multicenter studies with standardized workflows are needed to enhance clinical applicability and reproducibility.

In recent decades, the use of 4D Flow MRI images has enabled the quantification of velocity fields within a volume of interest and along the cardiac cycle. However, the lack of resolution and the presence of noise in these biomarkers are significant issues. As indicated by recent studies, it appears that biomarkers such as wall shear stress are particularly impacted by the poor resolution of vessel segmentation. The Phase Contrast Magnetic Resonance Angiography (PC-MRA) is the state-of-the-art method to facilitate segmentation. The objective of this work is to introduce a new handcraft feature that provides a novel visualisation of 4D Flow MRI images, which is useful in the segmentation task. This feature, termed Weighted Mean Frequencies (WMF), is capable of revealing the region in three dimensions where a voxel has been passed by pulsatile flow. Indeed, this feature is representative of the hull of all pulsatile velocity voxels. The value of the feature under discussion is illustrated by two experiments. The experiments involved segmenting 4D Flow MRI images using optimal thresholding and deep learning methods. The results obtained demonstrate a substantial enhancement in terms of IoU and Dice, with a respective increase of 0.12 and 0.13 in comparison with the PC-MRA feature, as evidenced by the deep learning task. This feature has the potential to yield valuable insights that could inform future segmentation processes in other vascular regions, such as the heart or the brain.

Sarcopenia, defined as the progressive loss of skeletal muscle mass and function, has been associated with poor prognosis in patients with pancreatic cancer, particularly those with borderline resectable pancreatic cancer (BRPC). Although body composition can be extracted from routine CT imaging, sarcopenia assessment remains underused in clinical practice. Recent advances in artificial intelligence (AI) offer the potential to automate and standardize this process, but their clinical translation remains limited. This narrative review aims to critically evaluate (1) the clinical impact of CT-defined sarcopenia in BRPC, and (2) the performance and maturity of AI-based methods for automated muscle and fat segmentation on CT images. A dual-axis literature search was conducted to identify clinical studies assessing the prognostic role of sarcopenia in BRPC, and technical studies developing AI-based segmentation models for body composition analysis. Structured data extraction was applied to 13 clinical and 71 technical studies. A PRISMA-inspired flow diagram was included to ensure methodological transparency. Sarcopenia was consistently associated with worse survival and treatment tolerance in BRPC, yet clinical definitions and cut-offs varied widely. AI models-mostly 2D U-Nets trained on L3-level CT slices-achieved high segmentation accuracy (mean DSC >0.93), but external validation and standardization were often lacking. CT-based AI assessment of sarcopenia holds promise for improving patient stratification in BRPC. However, its clinical adoption will require standardization, integration into decision-support frameworks, and prospective validation across diverse populations.